• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[ST段抬高型心肌梗死的急性干预]

[Acute intervention for ST-elevation myocardial infarction].

作者信息

Heintzen M P

机构信息

Klinik für Kardiologie, Pneumologie und Angiologie, Medizinische Klinik II, Klinikum Braunschweig gGmbH, Braunschweig.

出版信息

Dtsch Med Wochenschr. 2008 Dec;133 Suppl 8:S266-9. doi: 10.1055/s-0028-1100959. Epub 2008 Dec 15.

DOI:10.1055/s-0028-1100959
PMID:19085804
Abstract

Rapid revascularization of every presenting patient is the goal of modern therapy of ST-elevation myocardial infarction (STEMI). With respect to the current situation at least one half of all these patients will be treated medically using thrombolysis, prehospital or in hospital. Invasive diagnosis and revascularization (percutaneous intervention [PCI], coronary artery to bypass graft [CABG]) should be done promptly. Primary PCI performed in a timely manner by experienced interventional cardiologists in specialized centers is the best option in the management of patients with STEMI. Transfer PCI is an effective method of treatment for patients initially admitted to a hospital without PCI facilities and should be completed within 90 minutes of transfer time. Rescue-PCI following unsuccessful thrombolysis (< 50 % ST-resolution 90 minutes post thrombolysis) improves prognosis by restoring coronary flow. If planned immediate PCI after thrombolytic therapy is not indicated, PCI immediately after high dosage of glycoprotein IIb/IIIa-Inhibitors in combination with a high dose of clopidogrel may give good results.

摘要

让每一位就诊患者迅速实现血管再通是ST段抬高型心肌梗死(STEMI)现代治疗的目标。就目前情况而言,所有这些患者中至少有一半将接受药物溶栓治疗,无论是在院前还是院内。应及时进行有创诊断和血管再通(经皮介入治疗[PCI]、冠状动脉旁路移植术[CABG])。由经验丰富的介入心脏病专家在专业中心及时进行的直接PCI是STEMI患者管理的最佳选择。转运PCI是最初入住无PCI设施医院的患者的一种有效治疗方法,应在转运时间90分钟内完成。溶栓失败后(溶栓后90分钟ST段回落<50%)进行补救性PCI可通过恢复冠状动脉血流改善预后。如果溶栓治疗后不适合立即进行计划中的直接PCI,那么在高剂量糖蛋白IIb/IIIa抑制剂联合高剂量氯吡格雷后立即进行PCI可能会取得良好效果。

相似文献

1
[Acute intervention for ST-elevation myocardial infarction].[ST段抬高型心肌梗死的急性干预]
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 8:S266-9. doi: 10.1055/s-0028-1100959. Epub 2008 Dec 15.
2
Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.对于入住社区医院的ST段抬高型心肌梗死(STEMI)患者,在进行直接经皮冠状动脉介入治疗时,使用血小板糖蛋白IIb/IIIa抑制剂进行转运是否比现场溶栓更有效?一项随机研究。早期结果。
Kardiol Pol. 2006 Aug;64(8):793-9; discussion 800-1.
3
Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score.院前糖蛋白IIb/IIIa抑制剂对ST段抬高型心肌梗死且出血风险高的患者的净临床获益:使用CRUSADE出血评分评估替罗非班对出血高风险患者的影响
J Invasive Cardiol. 2012 Mar;24(3):84-9.
4
Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.氯吡格雷预处理与急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后的住院病死率降低相关。
Eur Heart J. 2011 Dec;32(23):2954-61. doi: 10.1093/eurheartj/ehr360. Epub 2011 Sep 14.
5
Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative).急性ST段抬高型心肌梗死患者在接受直接经皮冠状动脉介入治疗前上游抗血小板治疗的模式(来自CRUSADE国家质量改进计划)
Am J Cardiol. 2008 Nov 15;102(10):1335-40. doi: 10.1016/j.amjcard.2008.06.063. Epub 2008 Sep 6.
6
Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis.急性ST段抬高型心肌梗死直接经皮冠状动脉介入治疗中糖蛋白IIb/IIIa抑制剂的早期与晚期给药:一项荟萃分析
JAMA. 2004 Jul 21;292(3):362-6. doi: 10.1001/jama.292.3.362.
7
Is delayed facilitated percutaneous coronary intervention better than immediate in reperfused myocardial infarction? Six months follow up findings.延迟的易化经皮冠状动脉介入治疗在再灌注心肌梗死中是否优于即刻介入治疗?六个月随访结果。
J Thromb Thrombolysis. 2006 Apr;21(2):147-57. doi: 10.1007/s11239-006-5733-z.
8
ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention.院前联合溶栓、院前启动的易化经皮冠状动脉介入治疗或直接经皮冠状动脉介入治疗再灌注的ST段抬高型心肌梗死患者的ST段恢复情况及预后
Am J Cardiol. 2006 Nov 1;98(9):1132-9. doi: 10.1016/j.amjcard.2006.05.044. Epub 2006 Sep 1.
9
Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.在ST段抬高型心肌梗死的经皮冠状动脉介入治疗期间,不同抗血小板治疗方案后实现的血小板聚集抑制。
J Am Coll Cardiol. 2004 Sep 15;44(6):1187-93. doi: 10.1016/j.jacc.2004.06.050.
10
Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).糖蛋白IIb/IIIa抑制剂与氯吡格雷单独及联合应用于非ST段抬高型心肌梗死的有效性和安全性(来自心肌梗死国家注册研究-4)
Am J Cardiol. 2006 Nov 1;98(9):1125-31. doi: 10.1016/j.amjcard.2006.05.043. Epub 2006 Aug 31.